PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 97 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $532,000 | +57.4% | 175,624 | +96.2% | 0.01% | +66.7% |
| Q4 2021 | $338,000 | +704.8% | 89,524 | +715.3% | 0.00% | – |
| Q2 2021 | $42,000 | -87.3% | 10,980 | -89.7% | 0.00% | -100.0% |
| Q2 2020 | $332,000 | +260.9% | 107,000 | +321.3% | 0.00% | +100.0% |
| Q4 2019 | $92,000 | -92.0% | 25,400 | -92.4% | 0.00% | -94.1% |
| Q3 2019 | $1,148,000 | +128.2% | 336,400 | +124.3% | 0.03% | +100.0% |
| Q1 2019 | $503,000 | +26.1% | 150,000 | 0.0% | 0.02% | +13.3% |
| Q4 2018 | $399,000 | -82.2% | 150,000 | -62.5% | 0.02% | -85.0% |
| Q3 2018 | $2,240,000 | -46.7% | 400,000 | -51.7% | 0.10% | -56.1% |
| Q2 2018 | $4,201,000 | -25.8% | 828,600 | -0.2% | 0.23% | -46.4% |
| Q1 2018 | $5,665,000 | +11.2% | 830,637 | +23.1% | 0.42% | +1.9% |
| Q4 2017 | $5,096,000 | +22.0% | 675,000 | -6.9% | 0.42% | +9.4% |
| Q3 2017 | $4,176,000 | +1.9% | 725,000 | -10.5% | 0.38% | -9.9% |
| Q2 2017 | $4,099,000 | – | 810,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |